கிரீன்விச் ஆயுள் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிரீன்விச் ஆயுள் அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிரீன்விச் ஆயுள் அறிவியல் Today - Breaking & Trending Today

1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?


Texas-based biotech 
Greenwich Life Sciences (NASDAQ:GLSI) is currently developing immunotherapy for use against certain types of breast cancer. Founded in 2006, the company was actually 2020 s top-performing IPO, appearing on the market at $5.75 in September and hitting a low of $3.26 in November before peaking at $72 in December, when news first broke regarding positive phase 2b results in breast cancer patients. Investors were ecstatic, but the boost didn t last. The stock ended up being shorted heavily until it stabilized and is currently at about $32.
What caused such a dramatic rise and fall, and is the stock s valuation appealing now? 
Image Source: Getty Images. ....

United States , Genentech Trastuzumab , Drug Administration , Greenwich Lifesciences , Image Source , Although Greenwich , ஒன்றுபட்டது மாநிலங்களில் , கிரீன்விச் ஆயுள் அறிவியல் , படம் மூல ,

Insider Buys Greenwich LifeSciences Shares

Insider Buys Greenwich LifeSciences Shares
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Patel Snehal , Greenwich Lifesciences Inc , Greenwich Lifesciences , படேல் சிந்ேல் , கிரீன்விச் ஆயுள் அறிவியல் இன்க் , கிரீன்விச் ஆயுள் அறிவியல் ,